CVE-2025-64186 — Evervault Go SDK: Incomplete PCR Validation in Enclave Attestation for non-Evervault hosted Enclaves
Evervault is a payment security solution. A vulnerability was identified in the `evervault-go` SDK’s attestation verification logic in versions of `evervault-go` prior to 1.3.2 that may allow incomplete documents to pass validation. This may cause the client to trust an enclave operator that does not meet expected integrity guarantees. The exploitability of this issue is limited in Evervault-hosted environments as an attacker would require the pre-requisite ability to serve requests from specific evervault domain names, following from our ACME challenge based TLS certificate acquisition pipeline. The vulnerability primarily affects applications which only check PCR8. Though the efficacy is also reduced for applications that check all PCR values, the impact is largely remediated by checking PCR 0, 1 and 2. The identified issue has been addressed in version 1.3.2 by validating attestation documents before storing in the cache, and replacing the naive equality checks with a new SatisfiedBy check. Those who useevervault-go to attest Enclaves that are hosted outside of Evervault environments and cannot upgrade have two possible workarounds available. Modify the application logic to fail verification if PCR8 is not explicitly present and non-empty and/or add custom pre-validation to reject documents that omit any required PCRs.
Who exploits it and how urgent it is
A 0–100 score combining confirmed exploitation, ransomware and APT use, public exploits, EPSS and severity.
How the score was calculated
- EPSS 0.1% (30-day exploitation probability)+1
- Technical severity (medium)+3
- CISA SSVC: exploitation "poc"+5
The score orders the patch queue; it does not replace your asset context (internet exposure, criticality, compensating controls).
Triage
Is it exploited, how likely is exploitation, what does it touch, and how severe do the sources call it.
CISA SSVC assessment CISA
Three decision points CISA publishes for the CVEs it assesses (SSVC 2.0.3). A stakeholder decision, not a severity score.
Remediation
Fixes and mitigations documented by the sources — linked to the original advisory.
- Documented patch — github.com (NIST National Vulnerability Database)
- Documented patch — github.com (NIST National Vulnerability Database)
First 24 hours
Ordered from the record’s own fields — exposure first, because you cannot patch what you have not found. A rule-generated starting point.
- Identify exposed assets running the affected vendor/product/version combinations (Evervault Evervault, Evervault Evervault-go).
- Apply the fixed version or the patch documented under Remediation.
- Search available logs for exploit probes matching the vulnerability class (cryptography), errors and authentication anomalies.
Affected scope
Vendor, product and versions as the sources word them.
| Vendor | Product | Versions | Status | Source |
|---|---|---|---|---|
| Evervault | Evervault | < 1.3.2 | Vulnerable | NIST National Vulnerability Database |
| Evervault | Evervault-go | version < 1.3.2 | Vulnerable | CVE Program (cve.org) e CISA ADP |
Attack characteristics
The CVSS vector, decoded. It describes the attack, not your exposure to it.
Every base score collected
Sources score independently and may disagree; each row says who scored it and under which version.
| Score | Version | Severity | Expl. | Impact | Scored by |
|---|---|---|---|---|---|
| 8.7 | CVSS 3.1 | High | 2.3 | 5.8 | security-advisories@github.com via NIST National Vulnerability Database |
| 8.7 | CVSS 3.1 | High | — | — | GitHub_M via CVE Program (cve.org) e CISA ADP |
| 6.5 | CVSS 3.1 | Medium | 2.8 | 3.6 | nvd@nist.gov via NIST National Vulnerability Database |
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N (score shown at the top: nvd@nist.gov) Weakness MITRE
Weakness class according to MITRE’s CWE catalog.
EPSS over time FIRST
Oct 13, 2026 → Oct 14, 2026 · 2 reading(s) · max 0.15%
Detection
Read off the CVSS vector and the weakness class. Starting points, not tested rules.
- Prioritize edge telemetry for the network-reachable component (proxy, WAF, IDS/IPS).
- Check TLS negotiations and unexpected certificates in the component’s traffic.
Timeline
What happened to this CVE, newest first.
- 2026
- Affected products added · evervault/evervault-go
- SSVC assessment updated
- Record published
- Fix documented
- CVSS changed · 6.5
- Source status changed · → Analyzed
- Record created in this database
- 2025
- CVE published
Source activity
Repeated readings are counted rather than listed.
- 1× Official description updated · Oct 13, 2026 – Oct 13, 2026
References
3 on the record
Elsewhere on this site
Not in any source we poll
Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.
- No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
- No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
- No exploit packet captures, log samples, or incident case IDs supplied.
Answered from this record
Text assembled only from the fields above — no additional claims.
What should defenders know first?
CVE-2025-64186 is "Evervault Go SDK: Incomplete PCR Validation in Enclave Attestation for non-Evervault hosted Enclaves", rated Medium. It affects Evervault (Evervault); versions are in the scope table. It is not in CISA KEV, which does not rule out exploitation. CVSS 6.5 describes technical severity. EPSS 0.15% estimates the probability of exploitation in 30 days; neither replaces your asset context. First verify whether exposed or business-critical assets run the affected versions, apply vendor fixes or mitigations, and preserve logs for review.
Comments
Moderated technical discussion. Read the community guidelines.
No comments yet.
Sign in or create an account to comment and suggest corrections.